Three-D ultrasound examination shows the location, size, and perivesical spreading of bladder tumors just as well as conventional cystoscopy. The technique has the advantage of being noninvasive.
Three-D ultrasound examination shows the location, size, and perivesical spreading of bladder tumors just as well as conventional cystoscopy. The technique has the advantage of being noninvasive.
Bladder cancer is the fourth most common cancer in men in the U.S. and the 10th most common in women. It usually occurs in patients over 68 years of age, so a noninvasive way to evaluate cases in elderly patients could lower risks of complications.
Dr. Ercan Kocakoc and colleagues in the departments of radiology and urology at Firat University in Elazig, Turkey, published their study in the January issue of the Journal of Ultrasound in Medicine. They examined 31 patients with confirmed or suspected bladder cancer using 3D ultrasound within 15 days of conventional cystoscopy and compared the results.
Each ultrasound exam included gray-scale, 3D virtual, and multiplanar reconstruction images, which the researchers evaluated for the number, size, location, and morphologic features of lesions, providing a virtual cystoscopy.
The researchers obtained good or excellent image quality on 28 of the 31 virtual cystoscopies, or 90.3%. Conventional cystoscopy found 47 lesions in 22 patients. Virtual cystoscopy showed 41 or 87.2% of these 47 lesions.
For tumor detection, 3D sonography alone had a 96.2% sensitivity, 70.6% specificity, positive predictive value of 93.9%, and negative predictive value of 80%. A combination of gray-scale sonography, multiplanar reconstruction, and 3D virtual sonography detected tumors with a sensitivity of 96.4%, specificity of 88.8%, positive predictive value of 97.6%, and negative predictive value of 84.2%.
The researchers concluded that 3D ultrasound could be a promising noninvasive alternative to conventional methods of detecting bladder cancer, since the results of virtual cystoscopy agreed well with conventional cystoscopy.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
FDA Clears Point-Of-Care Ultrasound Platform and AI Software for Neuraxial Procedures
July 17th 2025The dual FDA clearances for the Accuro 3S point-of-care ultrasound device and the SpineNav-AI machine learning-based software may enhance precision and safety with ultrasound-guided neuraxial procedures.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.